SLI
1.967,44
PKT
-8,28
PKT
-0,42
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
30.06.15 | UBS buy | Citigroup Corp. | |
30.06.15 | UBS buy | Citigroup Corp. | |
30.06.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
30.06.15 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
26.06.15 | Roche buy | HSBC | |
26.06.15 | Novartis buy | HSBC | |
24.06.15 | Roche overweight | JP Morgan Chase & Co. | |
24.06.15 | Swiss Re Underweight | JP Morgan Chase & Co. | |
24.06.15 | Givaudan overweight | JP Morgan Chase & Co. | |
24.06.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
24.06.15 | Nestlé buy | Citigroup Corp. | |
23.06.15 | Novartis buy | Citigroup Corp. | |
22.06.15 | Zurich Insurance buy | Jefferies & Company Inc. | |
19.06.15 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
19.06.15 | Novartis overweight | JP Morgan Chase & Co. | |
18.06.15 | ABB (Asea Brown Boveri) Sell | UBS AG | |
17.06.15 | UBS buy | Deutsche Bank AG | |
17.06.15 | UBS buy | Deutsche Bank AG | |
17.06.15 | Nestlé Underperform | BNP PARIBAS | |
16.06.15 | Zurich Insurance Neutral | Citigroup Corp. | |
16.06.15 | Swiss Re buy | Citigroup Corp. | |
16.06.15 | Novartis buy | UBS AG | |
15.06.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
15.06.15 | Nestlé overweight | JP Morgan Chase & Co. | |
11.06.15 | Swiss Re buy | Citigroup Corp. | |
10.06.15 | Swiss Re buy | Goldman Sachs Group Inc. | |
10.06.15 | UBS buy | Goldman Sachs Group Inc. | |
10.06.15 | Holcim buy | Deutsche Bank AG | |
10.06.15 | Holcim buy | Deutsche Bank AG | |
10.06.15 | UBS buy | Goldman Sachs Group Inc. | |
09.06.15 | ABB (Asea Brown Boveri) Hold | HSBC | |
09.06.15 | Swiss Re Hold | Jefferies & Company Inc. | |
08.06.15 | Nestlé buy | Citigroup Corp. | |
08.06.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
08.06.15 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.06.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
05.06.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
05.06.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
04.06.15 | Novartis buy | Citigroup Corp. | |
03.06.15 | UBS Outperform | RBC Capital Markets |